GFPT1 and hereditary clear cell renal cell carcinoma: Our data with azaserine, an inhibitor of GFPT1, shown in Figure 4E, suggest that the “sensitive” type of renal cell carcinomas were also sensitive to azaserine in high-glucose medium (25 mM glucose), but this was not the case with the “resistant” type of renal cell carcinomas.